Solvay Ventures apprises of its equity investment in Kumovis, a German startup developing a cutting-edge 3D printing ecosystem for medical applications. Kumovis wants to shape the future of the production of medical devices due to 3D printing technologies, by enabling its manufacturing right at the point of care. The Kumovis R1 is an open 3D printing system based on Fused Layer Manufacturing that can use a wide range of thermoplastic materials, ranging from PLA to PEEK.
Solvay Ventures Invests in Kumovis
Published : May 15, 2026
